Dr. Kawauchi’s project, ‘Exploration of Therapeutic Target Molecules through Epigenomic Analysis of Medulloblastoma,’ has been awarded the 2023 Astellas Foundation for Research on Metabolic Disorders Research Grant. Over the next two years, we aim to elucidate the mechanisms that regulate the unique epigenome of medulloblastoma.

P.S.: With this support, our paper has been accepted by Developmental Cell. You can find the paper here.